doi: 10.12688/f1000research.15642.1 4 BianX.YangL.WuW.LvL.JiangX.WangQ.et al
Ueland T, Svardal A, Oie E, Askevold ET, Nymoen SH, Bjorndal B, et al
In an attempt to maintain access to this broader market, a compounders trade group brought a legal challenge against the FDA
Calocurb's data represents apples-to-apples comparison because they're measuring actual hormone levels and appetite effects in similar populations, unlike typical comparisons where ingredients like berberine might increase GLP-1 by 65% -- enough for blood glucose management or statistical significance but not appetite suppression or clinical significance
I have several listeners whove started on Ozempic or Mounjaro and see great success in bringing down their A1C [blood sugar levels]
[A systematic review of the effectiveness of alternative weight-loss products' ingredients]